ASP Drug Pricing - (3rd Quarter)
July 2021
Payment Allowance Limits for Medicare Part B Drugs

  • Note 1: Payment allowance limits subject to the ASP methodology are based on Jan 2021 (1st Quarter) ASP data.
  • Note 2: The absence or presence of a HCPCS code and the payment allowance limits in this table does not indicate Medicare coverage of the drug. Similarly, the inclusion of a payment allowance limit within a specific column does not indicate Medicare coverage of the drug in that specific category. These determinations shall be made by the local Medicare contractor processing the claim.
 
Page 17 * Effective Jul 1, 2021 through Sep 30, 2021
HCPCS Code Code Dosage Payment
Limit		 Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
J7518 - Mycophenolic acid, oral, 180 mg 180 MG 1.469 - - - - - -
J7520 - Sirolimus, oral, 1 mg 1 MG 5.573 - - - - - -
J7525 - Tacrolimus, parenteral, 5 mg 5 MG 215.744 - - - - - -
J7527 - Everolimus, oral, 0.25 mg 0.25 MG 5.933 - - - - - -
J7605 - Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms 15 mcg 11.283 - - - - - -
J7606 - Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms 20 MCG 11.614 - - - - - -
J7608 - Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram 1 GM 5.776 - - - - - -
J7611 - Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 1 MG 0.261 - - - - - -
J7612 - Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg 0.5 MG 0.294 - - - - - -
J7613 - Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 1 MG 0.043 - - - - - -
J7614 - Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg 0.5 MG 0.057 - - - - - -
J7620 - Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 2.5 MG/0.5 MG 0.117 - - - - - -
J7626 - Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg 0.5 MG 1.335 - - - - - -
J7631 - Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams 10 MG 2.579 - - - - - -
J7639 - Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 1 MG 47.791 - - - - - -
J7644 - Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 1 MG 0.199 - - - - - -
J7674 - Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg 1 MG 0.807 - - - - - -
J7677 - Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram 1 MCG 0.191 - - - - - -
J7682 - Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams 300 MG 34.744 - - - - - -
J7686 - Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg 1.74 MG 670.898 - - - - - -
J8501 - Aprepitant, oral, 5 mg 5 MG 4.194 - - - - - -
J8520 - Capecitabine, oral, 150 mg 150 MG 0.89 - - - - - -
J8521 - Capecitabine, oral, 500 mg 500 MG 2.734 - - - - - -
J8530 - Cyclophosphamide; oral, 25 mg 25 MG 1.143 - - - - - -
J8540 - Dexamethasone, oral, 0.25 mg 0.25 MG 0.048 - - - - - -
* Effective Jul 1, 2021 through Sep 30, 2021

Drugs not otherwise classified - July 2021

 

Medicare Part B payment allowance limits for drugs not otherwise classified - Effective Jul 1, 2021 through Sep 30, 2021

Drug name Dosage Payment limit Notes
Alfentanil Hcl 500 MCG 1.932
Allopurinol Sodium 500 MG 3320.364
Aminocaproic acid 250 MG 0.293
Aztreonam 500 MG 14.167
Bumetanide 0.25 MG 0.281
Bupivacaine 1 ML 0.089
Clindamycin Phosphate 150 MG 0.824
Coagulation Factor IX, Recombinant (Ixinity) 1 IU 2.21 includes clotting factor furnishing fee
Diltiazem Hydrochloride 5 MG 0.294
Doxycycline Hyclate 100 MG 19.079
Esmolol Hydrochloride 10 MG 0.312
Famotidine 10 MG 0.432
Flumazenil 0.1 MG 0.793
Folic Acid 5 MG 2.919
Glucarpidase 10 UNITS 345.308
Glycopyrrolate injection 0.2 MG 2.317
Immune Globulin (Cutaquig) 100 MG 13.394
Immune Globulin (Panzyga) 500 MG 62.968
Labetalol Hcl 5 MG 0.126
Metoprolol Tartrate 1 MG 0.141
Metronidazole inj 500 MG 1.138
Nitroglycerin 5 MG 1.28
Olanzapine short acting intramuscular injection 0.5 MG 1.282
Paliperidone Palmitate (Invega Trinza) 1 MG 10.524
Rabies Immune Globulin (Kedrab) 150 IU 243.784
Rifampin 600 MG 106.951
Sodium Chloride, Hypertonic (3% - 5% infusion) 250 CC 1.481
Sulfamethoxazole-Trimethoprim 400-80 MG 0.581
Vasopressin 20 UNITS 210.415

ASP (Average Sale Price) Drug Pricing History